PELL Bio-Med Technology Co. Ltd. (6949.TW)
TWD 117.5
(0.43%)
TWD 117.5
(0.43%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -398.75 Million TWD | -73.27% |
| 2022 | -230.13 Million TWD | -21.79% |
| 2021 | -188.95 Million TWD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -101.54 Million TWD | -19.05% |
| 2024 Q1 | -85.29 Million TWD | 11.78% |
| 2023 Q3 | -119.01 Million TWD | 2.94% |
| 2023 Q1 | -59.23 Million TWD | 1.77% |
| 2023 Q2 | -122.62 Million TWD | -107.02% |
| 2023 FY | -398.75 Million TWD | -73.27% |
| 2023 Q4 | -96.68 Million TWD | 18.77% |
| 2022 Q4 | -60.3 Million TWD | 10.29% |
| 2022 FY | -230.13 Million TWD | -21.79% |
| 2022 Q3 | -67.21 Million TWD | 0.0% |
| 2021 FY | -188.95 Million TWD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Apex Biotechnology Corp. | 115.78 Million TWD | 444.399% |
| Sinphar Pharmaceutical Co.,Ltd. | 375.17 Million TWD | 206.287% |
| Panion & Bf Biotech Inc. | 77.21 Million TWD | 616.396% |
| Chunghwa Chemical Synthesis & Biotech Co., Ltd. | 264.9 Million TWD | 250.526% |
| GenMont Biotech Incorporation | 32.99 Million TWD | 1308.681% |
| Abnova (Taiwan) Corporation | 43.67 Million TWD | 1012.945% |
| Adimmune Corporation | -639.89 Million TWD | 37.684% |
| Tanvex BioPharma, Inc. | -2.13 Billion TWD | 81.341% |
| Polaris Group | -1.57 Billion TWD | 74.709% |
| Energenesis Biomedical CO.,LTD. | -260.38 Million TWD | -53.143% |
| UnicoCell Biomed Co., Ltd. | -84.1 Million TWD | -374.1% |